IMPACT OF GLP-1 RECEPTOR AGONISTS ON LIVER ENZYMES AND FIBROSIS SCORES IN TYPE 2 DIABETIC AND NON-DIABETIC PATIENTS WITH FATTY LIVER DISEASE. (2026). Frontier in Medical and Health Research, 4(3), 4646-4654. https://fmhr.net/index.php/fmhr/article/view/3859